These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 17786164)

  • 21. Apical ABC transporters and cancer chemotherapeutic drug disposition.
    Durmus S; Hendrikx JJ; Schinkel AH
    Adv Cancer Res; 2015; 125():1-41. PubMed ID: 25640265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapies.
    Westover D; Li F
    J Exp Clin Cancer Res; 2015 Dec; 34():159. PubMed ID: 26714461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.
    Mimeault M; Hauke R; Mehta PP; Batra SK
    J Cell Mol Med; 2007; 11(5):981-1011. PubMed ID: 17979879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.
    Mimeault M; Mehta PP; Hauke R; Batra SK
    Endocr Rev; 2008 Apr; 29(2):234-52. PubMed ID: 18292464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the breast cancer resistance protein (ABCG2) in drug transport.
    Mao Q; Unadkat JD
    AAPS J; 2005 May; 7(1):E118-33. PubMed ID: 16146333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoscale drug delivery for taxanes based on the mechanism of multidrug resistance of cancer.
    Wang S; Qiu J; Shi Z; Wang Y; Chen M
    Biotechnol Adv; 2015; 33(1):224-241. PubMed ID: 25447422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview.
    Arrigoni E; Galimberti S; Petrini M; Danesi R; Di Paolo A
    Expert Opin Drug Metab Toxicol; 2016 Dec; 12(12):1419-1432. PubMed ID: 27459275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of UDP-glucuronosyltransferases and drug transporters in breast cancer drug resistance.
    Starlard-Davenport A; Lyn-Cook B; Beland FA; Pogribny IP
    Exp Oncol; 2010 Sep; 32(3):172-80. PubMed ID: 21403613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into the mechanisms of multidrug resistance in cancers.
    Montazami N; Aghapour M; Farajnia S; Baradaran B
    Cell Mol Biol (Noisy-le-grand); 2015 Nov; 61(7):70-80. PubMed ID: 26612736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug resistance mediated by ABC transporters].
    Yoshikawa M; Ito A; Ishikawa T; Ikegami Y
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):1-6. PubMed ID: 14750312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics.
    Ishikawa T; Nakagawa H
    J Exp Ther Oncol; 2009; 8(1):5-24. PubMed ID: 19827267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of nanomedicine in reversing drug resistance mediated by ATP binding cassette transporters and P-glycoprotein in melanoma.
    Kanwar JR; Singh N; Kanwar RK
    Nanomedicine (Lond); 2011 Jun; 6(4):701-14. PubMed ID: 21718179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of breast cancer resistance protein on cancer treatment outcomes.
    Ross DD; Nakanishi T
    Methods Mol Biol; 2010; 596():251-90. PubMed ID: 19949928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells.
    Porro A; Iraci N; Soverini S; Diolaiti D; Gherardi S; Terragna C; Durante S; Valli E; Kalebic T; Bernardoni R; Perrod C; Haber M; Norris MD; Baccarani M; Martinelli G; Perini G
    Mol Cancer Res; 2011 Aug; 9(8):1054-66. PubMed ID: 21693596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The new mechanisms and reversal of drug resistance].
    Akiyama S
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):1-8. PubMed ID: 12557697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
    Sun YL; Kathawala RJ; Singh S; Zheng K; Talele TT; Jiang WQ; Chen ZS
    Anticancer Drugs; 2012 Sep; 23(8):865-73. PubMed ID: 22614107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells.
    McIntosh K; Balch C; Tiwari AK
    Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):633-44. PubMed ID: 27116192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular diagnosis of ATP-binding cassette transporter-related diseases.
    Schuierer MM; Langmann T
    Expert Rev Mol Diagn; 2005 Sep; 5(5):755-67. PubMed ID: 16149878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.